Starting immediately or as negotiated.
The Department of Biomedicine (DBM) integrates basic and clinical researchers from University of Basel and University Hospitals committed to deepen the understanding of health and disease while driving the development of innovative therapies that address unmet medical needs.
With over 70 research groups and 800 employees, the Department of Biomedicine is the largest department within the University of Basel. Be part of our future!
The Wymann lab at the DBM Mattenstrasse, University of Basel, Switzerland, invites qualified candidates to apply for a post-doctoral position in Medicinal Chemistry. The candidate will join a multi-disciplinary team focusing on the development of new bioactive molecules targeting major signaling pathways in allergy, inflammation and cancer. Main targets are stress kinases vital for immune reactions, metabolic control and immune checkpoint modulation in cancer therapy.
The working place of the successful candidate is the Department of Biomedicine at Mattenstrasse 28, 4057 Basel.
Project:
Main focus: Targeting cell surface receptor signaling by newly designed covalent, PPI and allosteric inhibitors within an Innosuisse-funded project aiming to open a path to lead compounds for therapeutic applications.
For technically relevant recent publications see Borsari et al. (2022) J. Am. Chem. Soc. 144: 6326–6342; Bissegger et al. (2024) Chem. Sci., 15:20274-20291
This project is flanked by basic reasearch projects
i) developing novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a summary see: https://p3.snf.ch/project-204602.
ii) investigating of the role of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and cancer; see https://data.snf.ch/grants/grant/189065